1. Home
  2. SELX vs VTVT Comparison

SELX vs VTVT Comparison

Compare SELX & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SELX

Semilux International Ltd. Ordinary Shares

N/A

Current Price

$0.79

Market Cap

24.0M

Sector

N/A

ML Signal

N/A

Logo vTv Therapeutics Inc.

VTVT

vTv Therapeutics Inc.

HOLD

Current Price

$34.00

Market Cap

127.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SELX
VTVT
Founded
2021
2015
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.0M
127.0M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
SELX
VTVT
Price
$0.79
$34.00
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$37.00
AVG Volume (30 Days)
31.9K
12.4K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,667,724.00
$17,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
266.10
N/A
52 Week Low
$0.52
$13.15
52 Week High
$1.85
$35.95

Technical Indicators

Market Signals
Indicator
SELX
VTVT
Relative Strength Index (RSI) 47.16 70.06
Support Level $0.60 $22.92
Resistance Level $0.70 $35.95
Average True Range (ATR) 0.09 2.23
MACD 0.01 0.59
Stochastic Oscillator 46.81 89.87

Price Performance

Historical Comparison
SELX
VTVT

About SELX Semilux International Ltd. Ordinary Shares

Semilux International Ltd is a company that operates through its subsidiaries which is an optical and 3D sensing technology company that is involved in the customization, design and supply of optical components and integrated chip for various industries including autonomous driving, intelligent lighting, as well as unmanned aerial vehicles. In collaboration with its clients, TCO conceptualizes and produces high precision optics and sensing modules that are specifically customized to clients' needs for ease of integration in overall design and production. Applications for TCO's products include automotive laser headlight systems, adaptive driving beams (ADB) as well as light detection and autonomous driving systems (LiDAR).

About VTVT vTv Therapeutics Inc.

vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin, currently in a Phase 3 trial, a potential novel first-in-class oral liver-selective glucokinase activator being investigated for the treatment of type 1 diabetes. The group and its development partners are investigating multiple molecules across different indications for chronic diseases. Its product pipeline are HPP737, Azeliragon, TTP-RA, TTP273, HPP971 / HPP3033, and HPP593.

Share on Social Networks: